Resonance Specialties Limited
Quick Take
- • Trading at 13.5× trailing earnings
- • Strong ROE at 19.8%
- • Low leverage (D/E 0.03)
- • Modest dividend yield of 0.61%
- • Operating margin 21.9% · Net margin 14.3%
- • Profit growth +253.20% YoY · Beta 0.48
Latest quarter · Jun 2026
| ₹ Cr | Jun 2026 | QoQ | YoY |
|---|---|---|---|
| Revenue | 33 | +37.50% | +57.14% |
| Operating Profit | 8 | +33.33% | +166.67% |
| Net Profit | 6 | +20.00% | +200.00% |
| EPS (₹) | 4.98 | +25.13% | +253.19% |
Shareholding Pattern
About the company
From latest AR & concallResonance Specialties Limited engages in the manufacture and marketing of specialty chemicals in India and internationally. It offers pyridine, a chemical used in agrochemicals, pharmaceuticals, latexes, food, and allied industries, as well as to manufacture vitamins, medicines, food flavoring, dyes, adhesives, pesticides, herbicides, etc.; and picolines, including beta and gamma picolines used in manufacturing vinyl latex rubber, vitamin B3, and anti-tuberculosis drugs. The company also provides nutritional drug products, such as zinc and chromium picolinate, chromium polynicotinate, niacin, pyrazinamide and isoniazid; alpha picolinic and dipicolinic acids; solvents comprising acetonitrile and valeronitrile; and lutidines and collidines for anti-ulcer drugs. The company was formerly known as Armour Polymers Limited. Resonance Specialties Limited was incorporated in 1989 and is based in Mumbai, India.
